Pfizer Launches Mass Recall On Lipitor Drug
Pfizer Recall of Lipitor Drug
Pfizer Inc – 30th October 2010
Today, Pfizer have launched a mass recall on their Lipitor drug amidst claims that cholesterol reduction tablet was giving off odors which resembled moldy and musty material that was damp.
The manufacturer based in New York have told press that they have recalled a total number of 38,000 bottles of the 40 milligram drug, which appears to have only been dispensed in the USA.
Concerns were sparked after two users of the drug reported the damp odor coming from the bottles, which Pfizer have now confirmed were supplied by another bottle manufacturer.
This is the third time in as many months that Pfizer have been caught by this odor, one in August and two in October – where by they have had to recall close to half a million bottles in total.
No matter what this recall brings to the surface, it’s pretty simple to say that the drug industry have had a strange year of it, with Johnson & Johnson having to recall some non-prescription drugs which could be purchased directly over the counter, and GlaxoSmithKline who had to settle an out of court payment of $750million regarding the case which was paced against them with respect to the Puerto Rico manufacturing deficiencies.
A spokesman for Pfizer said that they were taking more than adequate steps to solve the problems, adding that they were already starting to use specialist plastic pallets in a hope it will drastically reduce the possibilities of contamination within the bottles.
